INDOCO REMEDIES LTD. - 532612 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for Financial year ended 31.03.202115-06-2021
15-06-2021
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Resignation of Chief Financial Officer11-06-2021
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Written Transcript of Conference Call held on May 25, 202104-06-2021
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Audited Financial Results for the quarter and financial year ended 31.03.202126-05-2021
Indoco Remedies zooms 20% on strong revenue from international business
The company's export formulations grew 65.6 per cent YoY to Rs 132 crore, driven by strong growth in regulated and emerging markets26-05-2021
Indoco Remedies Ltd - 532612 - Announcement Under Reg 30 (LODR) (Updates)
Link of Audio recording of Conference Call held on May 25, 202125-05-2021
Indoco Remedies Ltd - 532612 - Regulation 23(9) - Related Party Transactions
Related Party transactions25-05-2021
Earnings Call for Q4FY21 of Indoco Remedies
Conference Call with Indoco Remedies Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript. <25-05-2021
Indoco Remedies Ltd - 532612 - Corporate Action-Board approves Dividend
Dividend for the year 2020-202125-05-2021
Indoco Remedies Ltd - 532612 - Board recommends Dividend
Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2021, inter alia, has recommended dividend of Rs. 1.50/- per share (75%) on face value of Rs. 2/- each for the financial year 2020-2021, subject to the Members approval at the AGM.25-05-2021